Thank you to Harvard University and Tel Aviv University for hosting the prestigious Venture Capital Summit which brought together distinguished leaders in tech, VC, and academia. Dr. Yair Schindel, MD, MBA who participated in the GP panel shared some of the powerful messages from the event: - Alan Feld "The Israeli tech and VC industry doesn’t need incentives—just the removal of disincentives." - Chemi Peres "We need fewer unicorns (>$1B) and more giraffes (>$1T)." - Jeremy Coller challenged everyone to think critically about how to work together and accelerate the Israeli tech and VC industry. Thank you to Harvard Business School, Tel Aviv University - Coller School of Management, and Jeremy Coller for making this event possible, and to Professors Josh Lerner and Paul Gompers for returning to Israel to share their invaluable insights. At aMoon, we are inspired to continue supporting Israeli entrepreneurs and advancing HealthTech innovation as part of our mission to accelerate cure in Israel and beyond. Ariel Porat | Yael Steinhart | Naftali Bennett | Dror Bin | Daniel Tsiddon | Liad Agmon | Adam Fisher | Dan Weiss | Eli Barkat | Merav Levin | Nisan Langberg | Shai Bernstein | Naomi Hausman | Sabrina Howell
aMoon Fund
Venture Capital and Private Equity Principals
Ra'anana עוקבים, Israel 9,654
Accelerating Cure
עלינו
aMoon is a global HealthTech and Life Sciences investment fund based in Israel. As Israel’s largest HealthTech fund, with $1.1 billion AUM, we partner with outstanding entrepreneurs who harness groundbreaking science and technology to transform healthcare. Together with our portfolio companies, we work tirelessly to advance solutions that will help people live healthier, better lives. We harness our unique team of over 50 scientists, physicians and entrepreneurs and our global network of investors and industry leaders to build bridges between our portfolio companies and global tech, finance and medical research hubs to help entrepreneurs turn their vision into reality. Through our Velocity Fund we invest in companies pursuing disruptive, cutting-edge technologies as early as venture formation through Series A. Our Growth Fund invests in later-stage companies that are either generating revenue in growth rounds, pre-IPO rounds or in pivotal clinical trials.
- אתר אינטרנט
-
http://amoon.fund/
קישור חיצוני עבור aMoon Fund
- תעשייה
- Venture Capital and Private Equity Principals
- גודל החברה
- 11-50 עובדים
- משרדים ראשיים
- Ra'anana, Israel
- סוג
- שותפות
- הקמה
- 2016
- התמחויות
מיקומים
-
הראשי
34 Jerusalem Road
Ra'anana, Israel 4350108, IL
עובדים ב- aMoon Fund
עדכונים
-
Come hear Roy Wiesner discuss the ins-and-outs of HealthTech start-ups this Thursday at Amit, Pollak, Matalon & Co.
עמית, פולק, מטלון ושות' שמחים להזמינכם לאירוע בוקר בו נדון באתגרים ובהזדמנויות שמחכים לסטארטאפים צעירים בתחום ה-HealthTech 💡 במהלך האירוע נשמע את סיפורו מעורר ההשראה של פרופ' גדי קרן, על הדרך הארוכה עד להצלחה, ונדון עם אנשי מפתח בתעשיית ה-HealthTech על הסיכונים וההזדמנויות העומדים בפני סטארטאפים צעירים 🚀, אופציות מימון 💰, תכנון אסטרטגי 📊, ושיתופי פעולה פוטנציאליים 🌍 שיכולים להאיץ את הצלחתם. מספר המקומות מוגבל, לחצו כאן להרשמה >> https://lnkd.in/dpeTY4i3 Chagit Pedael Levin | David Kishony | Benjamin Soffer | Dr. Gal Noyman - Veksler | Roy Wiesner #HealthTech #Startups #Innovation #VetureCapital #TechEvents
-
Yesterday, we had the privilege of hosting an event, Spotlight on MedTech Strategic Relationships in conjunction with Medtronic. The event explored the opportunities and challenges of strategic partnerships in the MedTech industry, offering insights from some of the leading voices in the field. We heard from inspiring speakers and an engaging panel discussion led by Yair Schindel, MD, MBA and Osnat Hakimi. Key Takeaways: - Ori Hadomi of Medtronic walked us through his journey with Mazor Robotics, and shared that most successes are built on a foundation of lessons learned from past mistakes. - Dr. Irit Yaniv of Almeda Ventures shared wise words on navigating strategic relationship "If you manage to get the elephant into the boardroom, learn to tame it." - Building impactful relationships requires reaching as high as possible within a strategic corporation, according to Gilad Marom of Restore Medical - Eran Meyer of Philips discussed the delicate dance between startups and corporations. - Timing is everything as you take the next step, so said Tammy Gilon of Laminate Medical Technologies Ltd.. - Boaz Lifschitz of Peregrine Ventures sees a resilient ecosystem with a bright future - Our very own Yael Gruenbaum-Cohen is inspired by the performance of Israeli MedTech companies as they continue to outperform in exits and returns A heartfelt thank you to our Medtronic co-hosts Arik Corcos and Dor Lavi, our speakers, panelists, and all who joined us for this event. The discussions highlighted the power of collaboration in driving innovation and transforming healthcare globally. Shira Oberlander | Tomer Berkovitz | Todd Sone | Moshe Mor | Yaron Daniely | Roy Wiesner | Reut Shema | Gaby Hirsch #MedTech #Innovation #StrategicPartnerships #aMoon #Medtronic #HealthcareTransformation
-
These exciting opportunities to join our investment teams are still open! If any of these roles sound right for you, don't hesitate to apply.
🚀 We're Hiring! We are excited to share three unique opportunities to join aMoon's investment teams and help shape the future of healthtech innovation. If you are passionate about digital health, thrive in dynamic environments, and want to be part of a leading healthtech VC fund, read about our open positions below: 🔬 Scientific Analyst/Associate - aMoon Growth 📍 Location: Raanana, Israel Join our interdisciplinary Growth investment team where you can gain invaluable hands-on experience in late-stage HealthTech investment. 📊 Business Analyst/Associate - aMoon Growth 📍 Location: Boston, MA, USA (local applicants only) Become a core member of our Growth investment team in Boston. 🧬 Biotech Analyst/Associate - aMoon Edge 📍 Location: Raanana, Israel A unique opportunity to collaborate with a seasoned team of professionals while honing your investment and analytical skills. At aMoon, we are committed to accelerating the pace of health innovation and shaping the future of healthcare. These roles offer the chance to be part of a fast-paced environment where you can grow, learn, and make a real difference. Interested or know someone who would be a great fit? Click the link to learn more and apply today! #hiring #digitalhealth #investment #healthcare #biotech #venturecapital #careers #aMoon #Boston #Israel https://jobs.amoon.fund/
-
Congratulations Air Doctor on the partnership with Allianz Partners USA! Through the Allyz® mobile app, international travelers in over 85 countries can now easily schedule virtual or in-person doctor visits. With multi-lingual doctors and no up-front costs for up to three consultations per trip, this partnership is setting a new standard for accessible healthcare on the go. Air Doctor’s innovative digital solution ensures travelers can confidently explore the world, knowing that quality medical care is just a few clicks away. Congratulations to the Air Doctor team for achieving this milestone!✈️ #HealthTech #Innovation #TravelHealth #GlobalCare #DigitalHealth Yair Schindel, MD, MBA | Tomer Berkovitz| Todd Sone | Osnat Hakimi | Tamir Maixner | Adam Kotzen | Gaby Hirsch
🗞️ BIG NEWS: We’re honored to partner with Allianz Partners USA to transform the way international travelers access healthcare! 🌎 Through this collaboration, policyholders can now effortlessly schedule doctor visits wherever they are, ensuring peace of mind and trusted medical care on-the-go. This is another step in our mission to make global travel healthier, safer, and more convenient. Read the full story here: https://lnkd.in/dcpecmvT #Partnerships #TravelInsurance #TravelHealthcare #Innovation
-
aMoon Fund פרסם מחדש את זה
Amazing initiative by the Teva Pharmaceuticals team to drive innovation. You're welcomed to join us! Kudos to Dana Bar-On and team for driving this!
-
We’re thrilled to see our very own Yael Gruenbaum-Cohen featured on the latest episode of the Triple & Co - Powering Growth with Lihi Pinto! 🎧 As a partner at aMoon and head of aMoon Alpha, Yael is a driving force in Israel’s HealthTech ecosystem, combining her expertise as a scientist and entrepreneur to create a diverse and sustainable tech future. In this episode, recorded live at the Women in Front conference in Jerusalem, Yael shares her insights on leadership, the power of kindness, and the foundations of her success. A huge thank you to Women in Front hosts Hilla Bakshi and Meytal Bercovich for creating a space to spotlight trailblazing women and to Dafniel Magen for producing this inspiring episode. 🎙️ Listen here: https://lnkd.in/djVqydpc #TripleAndCo #Podcast #StartUpNation #WomenInTech #HealthTech #Leadership
Executing SaaS B2B Growth Strategies for Startups | CRO as a Service | Driving Growth and Market Leadership
🎙️ New Episode Alert: Triple & Co - Powering Growth with Lihi Pinto Host Podcast! 🎧 In our latest episode, Dr. Shani Horowitz-Rozen sits down with Yael Gruenbaum-Cohen, the incredible investor at aMoon. Yael is driving Israel’s HealthTech sector forward with strategic investments and shared her expertise as a key speaker at the Women in Front conference in Jerusalem, hosted by the inspiring Hilla Bakshi and Meytal Bercovich Berkovits. A scientist and entrepreneur, Dr. Yael Greenbaum-Cohen, is committed to building a diverse, resilient, and sustainable tech ecosystem in Israel. Tune in to hear her thoughts on the power of kindness and what she believes has been the foundation of her success. 🎧 Don’t miss this insightful conversation from the Women in Front conference! Special thanks to Dafniel Magen for expertly producing this episode. https://lnkd.in/djVqydpc #TripleAndCo #Podcast #StartUpNation #WomenInTech #SaaS #Leadership
-
Exciting news from Theranica! Last week Theranica announced an expanded FDA indication for Nerivio®, making it the first and only FDA-cleared, non-drug treatment for acute migraine in children aged eight and above. This milestone establishes Nerivio® as the sole prescribed option for both acute and preventive treatment in this age group. We are proud to support Theranica on their journey of innovation as they advance migraine care. Yair Schindel, MD, MBA | Todd Sone | Tomer Berkovitz | Osnat Hakimi | Tamir Maixner | Adam Kotzen | Alon Ironi
FDA expands indication for Nerivio® as the first-and-only REN wearable for migraine treatment for children aged 8 and above! We are thrilled to announce that the FDA has expanded the indication for the Nerivio REN wearable for use in children as young as 8 years old. This is a significant step forward in providing a safe, drug-free migraine treatment for the pediatric population. Migraine is a debilitating neurological disease that affects 1 billion people worldwide, including 1 in 10 children.[1,2] Treatment options for children 8 and above are extremely limited and often not well tolerated. The REN wearable, a non-drug, non-disruptive option, fills a crucial gap in care and is the only preventive option that is FDA indicated for this patient age group. “For children and adolescents, uncontrolled migraine disease can negatively impact life trajectory and potentially lead to other disabilities. Early and effective intervention is critical, however more options for effective treatment are needed, specifically in patients younger than 12 years old,” said Dr. Trevor Gerson, MD, associate professor of pediatrics with the University of Missouri-Kansas City School of Medicine and associate program director of the Headache Medicine Fellowship. This expanded indication is not just a win for families, but a transformative step in redefining migraine care for younger patients. Learn more here: https://lnkd.in/g7RQ4smm —--------------------------------------------------- 1. Amiri et al, “Migraine, A Review on Its History, Global Epidemiology, Risk Factors, and Comorbidities”, 2022. 2. Khalil et al, “Migraine Headache in Childhood”, 2023.
-
Exciting news from caVos Biotherapeutics! At aMoon, we are committed to empowering visionary companies like caVos, who are transforming the landscape of precision medicine with their cutting-edge evolutionary intelligence and computational genomic algorithms. Congratulations to the entire caVos team for this achievement! We look forward to the great things to come. Yair Schindel, MD, MBA | Yaron Daniely | Moshe Mor | Yael Gruenbaum-Cohen | Roy Wiesner | Vered Gigi, PhD
We’re thrilled to announce the successful close of our latest funding round, raising $3.3M, led by Entrée Capital , in partnership with the Israel Innovation Authority רשות החדשנות , NFX, Alumni Ventures, and Tal Ventures. This achievement brings us one step closer to leveraging our evolutionary intelligence and computational genomic algorithms to develop the next generation of precision medicines. This accomplishment wouldn’t have been possible without the invaluable help and guidance of the aMoon Fund, Dr. Yaron Daniely, Dr. Yael Gruenbaum-Cohen and Dr. Vered Gigi, PhD. We are immensely grateful for their expertise, encouragement, and unwavering support throughout this journey. Thank you to everyone who has supported us so far—there’s a lot more to come. Stay tuned! Ohad Tarcic, Prof. Yuval Tabach, Miriam Shtilman Lavsovski, Omri Amirav-Drory, Ron Levin, Ran Achituv
-
Congratulations to MetaSight Diagnostics, an Israeli-based leader in liquid biopsy technology, on the over-subscribed series A funding round, announced today! This fundraise reinforces our belief in MetaSight’s innovative approach to diagnostics and its potential to revolutionize early disease detection. The company is setting a new standard for non-invasive diagnostics, starting with early-stage detection of colorectal cancer and expanding into other critical disease areas. We are excited to continue this journey with MetaSight as they push the boundaries of diagnostics and contribute to a brighter, healthier future. Yair Schindel, MD, MBA | Tomer Berkovitz | Yaron Daniely | Moshe Mor | Todd Sone | Roy Wiesner | Yael Gruenbaum-Cohen | Adam Kotzen | Tomer Shlomi | Saban Ventures | Arc Ventures | Alumni Ventures | Israel Innovation Authority רשות החדשנות | Technion - Israel Institute of Technology | Technion Angels
MetaSight Diagnostics Raises $8M in Over-Subscribed Series A Funding Round
globenewswire.com